Rocuronium

An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quaternary structure and is a weaker nicotinic antagonist than PANCURONIUM.

Year introduced: 2019 (1989)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D04.210.500.054.040.783

MeSH Unique ID: D000077123

Registry Number: WRE554RFEZ

Entry Terms:

• Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-
• 1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
• ORG-9426
• ORG9426
• ORG 9426
• Rocuronium Bromide
• Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
• Zemuron
• Esmeron
• Esmerone

Pharmacologic Action:

• Neuromuscular Nondepolarizing Agents

All MeSH Categories
Chemicals and Drugs Category
Polycyclic Compounds
Fused-Ring Compounds
Steroids
Androstanes
Androstanols
Rocuronium